We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Beyond Capital
IXP Lifesciences Catalyst Fund is an early-stage venture capital platform focused on supporting Lifesciences startups from pre-seed to Series A. Built by industry veterans, the fund combines capital with ecosystem support, venture studio capabilities, and deep domain expertise to help scientists and innovators translate research into scalable businesses across biopharma, medical technology, nutraceuticals, cosmeceuticals, and specialty chemicals.
IXP operates as a strategic partner rather than a passive investor, focusing on value creation, collaboration, long-term alignment, and leveraging deep industry expertise. The fund emphasizes tailored support for each startup’s journey, fostering innovation through ecosystem-driven partnerships instead of a one-size-fits-all investment approach.
Ketki Tulpule
Chief Innovation Officer
Techno-commercial professional with 15+ years of experience across Lifesciences, academia, and AI/ML-driven drug discovery. Formerly associated with Rx Propellant, Excelra, Aragen (GVK Bio), and Max Planck Institute.
Vishal Goel
Partner
Co-founder of JV Ventures with 20+ years in Lifesciences, consulting, and infrastructure development. Harvard alumnus with experience across EY, Alexandria Real Estate India, and Red Fort Capital.
Jasmeet Chhabra
Partner
Co-founder of JV Ventures with 20+ years of experience in investment and fundraising. Led capital raising across multiple funds totaling USD 600M+ with deep expertise in investor relations and scaling platforms.
Manoj Nerurkar
Advisor
Pharmaceutical veteran with 25+ years of experience from drug development to commercialization. Former COO of Syngene and leader at Bristol Myers Squibb and Novartis.
Nandu Gattu
Advisor
Expert in bioinformatics, pharmacology, and AI-driven drug discovery with 25+ years of experience across GSK, Excelra, and global research ecosystems.
Nirav Desai
Advisor
Biotechnology expert with 25+ years in biologics, vaccines, and process optimization. Former Head of Vaccines at Cadila Pharmaceuticals with multiple patents.
No insights published yet.
Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future returns.
Atin Tomar
Advisor
Biotech leader with 20+ years of experience across biologics and vaccines. Former CEO of CPL Biologics with academic credentials from IIT Kharagpur, University of Georgia, and ISB.